Edisson-Mauricio Pacheco-Quito, Daniel Avila-Cunalata, Katherine Cuenca-León
{"title":"Cariostatic Agents: From Silver Diamine Fluoride to Emerging Bioactive Compounds.","authors":"Edisson-Mauricio Pacheco-Quito, Daniel Avila-Cunalata, Katherine Cuenca-León","doi":"10.2147/CCIDE.S502433","DOIUrl":null,"url":null,"abstract":"<p><p>Cariostatic agents are bioactive compounds that inhibit the progression of dental caries by promoting enamel and dentin remineralization while mitigating dentin hypersensitivity. This review conducted an extensive bibliographic search across specialized databases, including Web of Science, PubMed, Cochrane Library, and Scopus, to present a comprehensive and up-to-date analysis of the clinical applications of cariostatic agents. A critical appraisal of the available scientific evidence was performed to evaluate their efficacy and potential as adjunctive therapeutic strategies in caries management. Among the most well-documented agents, silver diamine fluoride (SDF) demonstrates superior efficacy in arresting active carious lesions and preventing lesion progression. Furthermore, emerging bioactive compounds, such as remineralizing peptides and phytochemicals, have exhibited promising anticariogenic properties, though their long-term clinical effectiveness remains under investigation. This review synthesizes key findings from recent research, underscoring the pivotal role of cariostatic agents in evidence-based caries prevention and management. The results highlight the necessity of integrating these agents into a minimally invasive and patient-centered approach, particularly for high-risk populations, to optimize long-term oral health outcomes.</p>","PeriodicalId":10445,"journal":{"name":"Clinical, Cosmetic and Investigational Dentistry","volume":"17 ","pages":"237-257"},"PeriodicalIF":1.5000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12145146/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical, Cosmetic and Investigational Dentistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/CCIDE.S502433","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Cariostatic agents are bioactive compounds that inhibit the progression of dental caries by promoting enamel and dentin remineralization while mitigating dentin hypersensitivity. This review conducted an extensive bibliographic search across specialized databases, including Web of Science, PubMed, Cochrane Library, and Scopus, to present a comprehensive and up-to-date analysis of the clinical applications of cariostatic agents. A critical appraisal of the available scientific evidence was performed to evaluate their efficacy and potential as adjunctive therapeutic strategies in caries management. Among the most well-documented agents, silver diamine fluoride (SDF) demonstrates superior efficacy in arresting active carious lesions and preventing lesion progression. Furthermore, emerging bioactive compounds, such as remineralizing peptides and phytochemicals, have exhibited promising anticariogenic properties, though their long-term clinical effectiveness remains under investigation. This review synthesizes key findings from recent research, underscoring the pivotal role of cariostatic agents in evidence-based caries prevention and management. The results highlight the necessity of integrating these agents into a minimally invasive and patient-centered approach, particularly for high-risk populations, to optimize long-term oral health outcomes.
蛀牙剂是一种生物活性化合物,通过促进牙釉质和牙本质再矿化来抑制蛀牙的发展,同时减轻牙本质的过敏。本综述在专业数据库中进行了广泛的文献检索,包括Web of Science、PubMed、Cochrane Library和Scopus,以提供对龋齿抑制剂临床应用的全面和最新的分析。对现有的科学证据进行了批判性的评估,以评估它们作为龋齿管理辅助治疗策略的有效性和潜力。在文献最充分的药物中,氟化二胺银(SDF)在阻止活动性龋齿病变和预防病变进展方面表现出卓越的疗效。此外,新兴的生物活性化合物,如再矿化肽和植物化学物质,已经显示出有希望的抗肿瘤特性,尽管它们的长期临床有效性仍在研究中。本综述综合了近期研究的主要发现,强调了防龋齿剂在基于证据的龋齿预防和管理中的关键作用。结果强调了将这些药物整合到微创和以患者为中心的方法中的必要性,特别是对于高危人群,以优化长期口腔健康结果。